FDA Official Believes GenAI-enabled Tools Will Need to Be Assessed Like a Physician
MedicineHealth AdministrationPublic Policy
THE AI ANGLE
Producing open-ended clinical outputs that challenge medical device safety testingAn FDA official announced plans to evaluate generative artificial intelligence tools like physicians rather than standard medical software. These tools take unbounded inputs and produce open-ended outputs, which breaks older testing methods for medical devices. The agency is drafting policy guidance to assess the clinical judgment and safety boundaries of these models.
THE TEACHING ANGLE
Regulators and healthcare leaders must decide who holds legal and clinical accountability when an unpredictable model makes clinical decisions that cannot be tested against every scenario.Read the original at medcitynews.com Generate teaching or study materials
More in Medicine
- UK government met 137 businesses over AI datacentres – but no environmental groupsThe Guardian — Technology · October 27, 2026
- ICE plan to buy robot dogs spurs protest from hundreds of Boston Dynamics employeesArs Technica · October 27, 2026
- From Carnegie to Claude: AI wealth could reshape philanthropyPhys.org — Technology · October 27, 2026
- ‘Autonomy, not flesh’: RAF chief outlines AI drone-powered futureThe Guardian — AI · October 27, 2026
- ‘Digital hostile environment’: AI secretly being embedded across Home Office, report claimsThe Guardian — Technology · October 27, 2026